НовостиBenzingaBarclays Maintains Overweight on Omada Health, Lowers Price Target to $22 Barclays Maintains Overweight on Omada Health, Lowers Price Target to $22 Benzinga 2026.11.06 16:26 (GMT+0) Открыть на Benzinga Другие новости